论文部分内容阅读
目的:研究和分析氨溴索与利巴韦林联合使用治疗小儿上呼吸道感染疾病的临床疗效。方法:选取我院收治的279例小儿上呼吸道感染患者,按照随机的原则分为观察组137例和对照组142例,对于观察组患者给予氨溴索联合利巴韦林进行治疗,对照组患者则单一口服药物利巴韦林,治疗一周后,将疗效进行统计和对比。结果:观察组患者鼻塞、喉中痰鸣消失以及止咳时间明显短于对照组患者,组间对比差异具有统计学意义;观察组的总有效率为98.54%,明显高于对照组,该两组患者治疗有效率对比,亦存在着明显的差异(x2=3.713,P<0.05),具有统计学意义。结论:对于上呼吸道感染小儿患者,采用药物氨溴索与利巴韦林联合治疗的方法,能够快速缓解症状,治疗效果较为满意,非常值得在临床治疗中推广和应用。
Objective: To study and analyze the clinical efficacy of combination of ambroxol and ribavirin in the treatment of pediatric upper respiratory tract infection. Methods: A total of 279 pediatric patients with upper respiratory tract infection admitted to our hospital were randomly divided into observation group (n = 137) and control group (n = 142). Patients in observation group were given ambroxol combined with ribavirin The single oral drug ribavirin, after a week of treatment, the efficacy of statistical and comparison. Results: In the observation group, the nasal obstruction, the disappearance of phlegm in the larynx and the duration of cough suppression were significantly shorter than those in the control group. The differences between the two groups were statistically significant. The total effective rate in the observation group was 98.54%, significantly higher than that in the control group. There was also a significant difference (p <0.05) between patients treated with efficiency, with statistical significance. Conclusion: The combination of ambroxol and ribavirin can relieve the symptoms in children with upper respiratory tract infection. The treatment effect is satisfactory and it is worth to be popularized and applied in clinical treatment.